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Effect of Atmospheric Nitric Oxide (NO) on
Measurements of Exhaled NO in Asthmatic Children
E. Baraldi, MD,* N.M. Azzolin, MD, C. Dario, MD, S. Carra’, MD, R. Ongaro, MD, P. Biban, MD, and
F. Zacchello, MD
Summary. The measurement of exhaled nitric oxide concentrations [NO] may provide a simple,
noninvasive means for measuring airway inflammation. However, several measurement condi-
tions may influence exhaled NO levels, and ambient NO may be one of these. We measured
exhaled NO levels in 47 stable asthmatic children age 5 to 17 years and in 47 healthy children,
gender and age matched. Exhaled [NO] in expired air was measured by a tidal breathing method
with a chemiluminescence analyzer, sampling at the expiratory side of the mouthpiece. NO
steady-state levels were recorded. In order to keep the soft palate closed and avoid nasal
contamination, the breathing circuit had a restrictor providing an expiratory pressure of 3–4 cm
H2O at the mouthpiece. To evaluate the effect of [NO] in ambient air, measurements were
randomly performed by breathing ambient air or NO-free air from a closed circuit.
Breathing NO-free air, exhaled [NO] in asthmatics (mean ± SEM) was 23.7 ± 1.4 ppb, sig-
nificantly higher (P < 0.001) than in healthy controls (8.7 ± 0.4 ppb). Exhaled NO concentrations
measured during ambient air breathing were higher (49 ± 4.6 ppb, P < 0.001) than when
breathing NO-free air (23.7 ± 1.4 ppb) and were significantly correlated (r = 0.89, P < 0.001) with
atmospheric concentrations of NO (range 3–430 ppb). These findings show that 1) exhaled [NO]
values of asthmatic children are significantly higher than in healthy controls, and 2) atmospheric
NO levels critically influence the measurement of exhaled [NO]. Therefore, using a tidal breath-
ing method the inhalation of NO-free air during the test is recommended. Pediatr Pulmonol.
1998; 26:30–34. © 1998 Wiley-Liss, Inc.
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INTRODUCTION
Nitric oxide (NO) plays a role in many aspects of
normal pulmonary function, and is involved in airway
inflammatory responses of several airway diseases.1,2
The finding of increased concentrations of exhaled NO in
asthmatics3 has led to the suggestion that the measure-
ment of exhaled NO may provide a simple noninvasive
means of measuring airway inflammation and of moni-
toring whether treatment is effective.2,4,5 NO has been
detected in exhaled air by a number of investigators in
humans but the amounts reported differ considerably.6
Conditions of measurement critically affect the NO lev-
els obtained,6 and among these are fluctuations in ambi-
ent NO concentrations.7 In urban areas, atmospheric en-
vironmental NO may rapidly change over a few hours
within a day, probably in relation to traffic, and during
the winter it can often exceed 100–200 ppb. The possible
influence of ambient NO was considered and has been
debated since the first discovery of NO in exhaled air by
Gustaffson et al.8 Other reports have excluded its influ-
ence.4,9,10 The reasons that may explain the apparent dis-
appearance of ambient inhaled NO in the lung are not
clear. One of the major factors contributing to the partial
pressure of NO in the lungs is ventilatory exchange be-
tween NO in the lower airways and NO in room air.11 A
recent paper7 indicated that exhaled NO concentrations
correlate significantly with the inhaled ambient concen-
trations of NO. It is, therefore, important that measure-
ments of exhaled NO are made under standardized con-
ditions, considering all factors that could influence this
measurement.
The principal aim of this study was to define the con-
tribution of natural background NO on exhaled NO mea-
surements in children, using a tidal breathing technique.
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We also compared NO values of asthmatics to those of
healthy controls in order to confirm previous re-
ports5,12,13 in which asthmatic children presented with




Forty-seven children with stable asthma (12 females,
35 males, age 5 to 17 years, mean 10.2 ± 0.3 years)
attending the Pediatric Pulmonology/Allergy Out-Patient
Clinic of the Children’s Hospital of Padova were in-
cluded in the study. The diagnosis of asthma was based
on clinical history and examination, pulmonary function
parameters, and pulmonary function response to inhaled
beta-adrenergic agents, according to international guide-
lines.14 All children had a history of mild to moderate
asthma for at least 2 years. Thirty-seven children were
under continuous treatment: 29 subjects with inhaled ste-
roids at low doses (200–400 mcg/day of beclomethasone
dipropionate, or equivalent doses of fluticasone or budes-
onide), four with cromones, and four with oral theoph-
ylline. Ten patients were not under continuous therapy.
All patients used an inhaled bronchodilator on demand.
At the time of the study, the disease was well controlled
in all children. The presence of allergy was demonstrated
in 45 out of 47 children by positive skin-prick tests (dust
allergy was present in 71%, grass pollen allergy in 54%,
and alternaria allergy in 21%).
Healthy Controls
Forty-seven healthy children, age and gender matched
with asthmatics (12 females, 35 males, age 6 to 15 years,
mean 10 ± 0.4 years) were recruited in two public
schools of Padova. Their parents were asked to complete
a health questionnaire regarding respiratory or allergic
diseases. Healthy controls had no history of airway dis-
ease, allergy, or cardiac disease and were not taking any
medication. None of the subjects of the study (asthmatics
and controls) had any history or signs of respiratory tract
infection in the 3 weeks before the study.
Protocol
After a screening visit, each child performed a spirom-
etry, and a NO measurement was taken. In order to
evaluate whether ambient NO may influence values of
exhaled NO, two separate measurements of exhaled NO
were made in all asthmatic patients: children were ran-
domized to start breathing either ambient air or NO-free
air. Measurements were performed sequentially on each
subject on the same day. Ambient NO levels were always
recorded before the test. Comparisons of exhaled NO
concentrations between asthmatics and controls were
performed with the subjects breathing NO-free air. The
protocol was approved by our Institutional Review
Board, and informed consent was obtained from both the
parents and the children.
Determination of Exhaled NO Levels
Exhaled NO in expired air was measured by a tidal
breathing method (Fig. 1) using a chemiluminescence
analyzer (CLD 700 Al-Med, Ecophysics, Switzerland)
and modifying the experimental set-up proposed by Alv-
ing et al.3 according to the recommendations of the Eu-
ropean Respiratory Society6 for measurement in chil-
dren. The analyzer is sensitive to NO concentrations
between 1 and 1,000 ppb. All measurements were per-
formed in the morning between 9 AM and 1 PM. Children
were seated wearing a nose clip and were asked to
breathe at tidal volume through a mouthpiece and a two-
way valve to avoid rebreathing. The mouthpiece was
connected by a Teflon tube (5 mm internal diameter) to
the analyzer. Children were randomized to inhale ambi-
ent air or NO-free air. To exclude the effect of NO in
ambient air, the children breathed NO-free air obtained
by passing ambient air through a purafill converter. NO-
free air was stored in a 14 L collapsible reservoir main-
tained inflated to approximately 70–80%. NO levels
were analyzed continuously by the chemiluminescence
analyzer, sampling at a constant flow of 0.7 L/min. [NO]
reached a steady-state level during mouth breathing after
1–2 min without significant further fluctuations. NO lev-
els were recorded between the third and the sixth minute
of mouth breathing. The subjects were asked to breathe
without speaking or swallowing. The exhaled air that was
not withdrawn by sampling was scavenged through a
tube with a one-way valve to prevent contamination with
ambient air. In order to keep the soft palate closed,6 the
breathing circuit had an internal restrictor that created a
low resistance and provided a positive pressure of 3–4
cm H2O at the mouthpiece. Before entering the analyzer,
exhaled air was passed through a water vapor trap. The
accuracy of our method of measuring exhaled NO has
been previously reported in 22 healthy children.15 The
chemiluminescence analyzer operates over a wide range
of ambient temperatures (5–33°C) and humidity (0–95%)
without an adverse effect on measurement accuracy. Be-
fore each study, the chemiluminescence analyzer was
calibrated with a certified calibration mixture (300 ppb)
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of NO in nitrogen (SIAD, Bergamo, Italy) with guaran-
teed stability. The mixtures are prepared by a gravimetric
method using NO which has a purity of >99.9% certified
both by wet analysis and gaschromatographic analysis.
The mixtures are contained in aluminum cylinders whose
internal surfaces are treated to reduce porosity and im-
prove stability. Total NOx within the cylinder did not
exceed by more than 10 ppb the value of NO itself.
Spirometry
Spirometric parameters were measured with a 10 L
bell spirometer (Biomedin, Padova, Italy), and the best of
three maneuvers was recorded as a percentage (%) of
predicted reference values.16 The spirometer was regu-
larly calibrated with a certified volume syringe.
Statistical Analysis
All exhaled NO concentrations are reported in ppb.
The results are shown as mean ± SEM. For comparison
of NO measurements between children with asthma and
healthy children, a Mann-Whitney rank sum tests was
used. The relation between exhaled NO concentrations
breathing ambient air or NO-free air was evaluated by the
linear correlation coefficient. A P-value of less than 0.05
was considered significant.
RESULTS
One hundred and forty-one measurements of exhaled
NO were performed between September 1996 and April
1997. All children completed the protocol easily. Inhal-
ing NO-free air before the measurement, the mean value
of orally mixed exhaled NO in 47 asthmatic children was
23.7 ± 1.4 ppb (range 8–60 ppb); exhaled NO concen-
trations were significantly higher compared to healthy
controls (8.7 ± 0.4 ppb, range 3.5–15 ppb) (P < 0.001).
Breathing ambient air with different concentrations of
atmospheric NO, the mean value of exhaled NO in the
same asthmatic children was 49 ± 4.6 ppb (range 14–200
ppb), which was significantly higher in comparison to the
value found breathing NO-free air (23.7 ± 1.4 ppb, P <
0.001). The ambient background level of NO measured
before the tests during the study period ranged from 3–
430 ppb. We observed a significant correlation (r 4
0.89, P < 0.001) between exhaled NO values and inhaled
ambient concentrations of NO. Figure 2 shows the rela-
tionship between inhaled ambient and exhaled NO values
in 47 asthmatic children. This demonstrates that ambient
[NO] has an important influence on the measurements of
orally exhaled NO.
Spirometric measurements in asthmatic children were
in the normal range (mean FEV1 92.3 ± 1.4% pred, FVC
100 ± 1.3% pred). Control subjects also had normal lung
function values (mean FEV1 92.6 ± 2% pred, FVC 93.3
± 1.6% pred). There was no significant correlation (P 4
ns) between exhaled NO and FEV1 or FVC in asthmatic
or control children.
DISCUSSION
The major finding in this study was that natural back-
ground NO affects the measurement of orally exhaled
NO concentrations. Based on this observation we recom-
mend that the inhalation of NO-free air is of utmost
importance in standardizing measurements of exhaled
NO when a tidal breathing method is used. In northeast
Italy, ambient NO levels present wide fluctuations during
FIg. 1. Schematic illustration of the experimental set-up to mea-
sure exhaled NO.
Fig. 2. Relationship between ambient NO and orally exhaled NO
values in 47 asthmatic children (r = 0.89, P < 0.001).
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the year, varying from 2–3 ppb during the summer to up
to 300 ppb during the winter. Similar NO atmospheric
values have been reported in Finland6 and probably are
present in many industrialized urban areas. In order to
evaluate whether ambient NO may influence values of
exhaled NO concentrations, we performed sequentially
two separate measurements of exhaled NO levels, breath-
ing either ambient air or NO-free air. Orally mixed ex-
haled NO concentrations were higher when breathing
ambient air and significantly correlated with the inhaled
ambient concentrations of NO, as shown in Figure 2.
This observation proves that when breathing ambient air,
measured exhaled NO levels are dependent on the atmo-
spheric concentration of NO in inspired air. Our findings
are in accordance with recent data of Dotsch et al. 7 who,
in a large number of subjects, found a clear impact of
ambient NO on orally exhaled NO concentrations. This
stresses the impact of measurement conditions on the
results and confirms the need to perform measurements
in a carefully standardized manner. Hyde et al.11 devel-
oped equations to calculate NO production by the lower
airways, taking into account the transport of NO into the
perfusing blood as well as into the expired air. These
equations are valid when NO concentrations in room air
are negligible or the subject inhales NO-free air, but they
require a more complex solution when the partial pres-
sure of NO in the inspired air (i.e., NO in ambient air) is
significantly above zero. The threshold above which
measurements of exhaled NO may be affected by envi-
ronmental NO is not known at this time. From several
studies in healthy controls it can be deduced that values
of 7–8 ppb represent the normal concentrations of ex-
haled NO in humans.6,10,17,18 It is, therefore, likely that
ambient NO concentrations less than 8–10 ppb may not
significantly influence exhaled NO, but this still needs to
be demonstrated.
Previous reports have not shown a significant relation-
ship between ambient NO levels and exhaled NO levels,
nor did they consider the importance of ambient NO
levels.9,10,19 Using the method of a single slow exhala-
tion, inhalation of a single breath of NO calibration gas
(100–1,000 ppb) did not affect the exhaled NO in a small
group of normal subjects.4,9,20 Because NO is a highly
reactive gas, a rapid absorption from the lung and bind-
ing of inhaled NO to hemoglobin could be one explana-
tion of its rapid disappearance after a single high dose
inhalation. However, this experimental exposure to NO
does not reflect the condition in which moderately high
concentrations of atmospheric NO are inhaled for several
hours. In this latter condition, it is indeed possible that
the capability of the lung to absorb atmospheric inhaled
NO is limited. Recently, Byrnes et al.21 using a single
slow exhalation method in adults, demonstrated a clear
influence of ambient background [NO] on exhaled NO
concentration, and they concluded that a high inspired
level of NO makes the exhaled NO concentrations diffi-
cult to interpret.
The second finding of the present study was that, con-
sistent with previous observations,3,5,7,12 exhaled NO
levels in asthmatic children were significantly higher
than those of healthy age and gender matched controls.
As previously reported,7,9,15 we found no relationship
between the degree of airway obstruction, as measured
by percentage of predicted FEV1, and the levels of ex-
haled NO, however, the asthmatic children included in
this study had normal values of FEV1 and FVC.
In 1993, Alving et al.3 reported increased NO levels in
exhaled air of asthmatics. Current understanding sug-
gests that an upregulated expression of iNOS in bronchi-
al epithelium of asthmatic patients22 is the most likely
explanation of this phenomenon. Glucocorticoids are
known to inhibit the expression of iNOS and this has
been confirmed by studies in which both systemic10,12,15
and inhaled steroid treatment23 can significantly reduce
exhaled NO concentrations in a few days. In asthmatic
children treated with different doses of inhaled steroids a
dose dependency of exhaled NO has been reported, and
only those treated with the highest doses presented [NO]
values similar to those of healthy controls.5 Patients in
our study were treated with low doses of inhaled steroids
and this may explain why they still presented increased
values of NO with respect to controls.
In conclusion, our study provides evidence that atmo-
spheric NO may critically affect measured exhaled NO
concentrations, and we suggest the inhalation of NO-free
air during the tidal breathing test. In addition, we have
confirmed previous observations that exhaled NO levels
are significantly higher in children with asthma than in
healthy controls.
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